SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3042% above fair value
$23.16−0.25 (-1.07%)
Close on Nov 17, 2026Market cap $1.04BP/E –Yield 0.00%
Si-Bone EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Si-Bone's EPS for the twelve months ending Jun 30, 2026 was -$0.34. For fiscal 2025 it was -$0.44. The highest annual figure on record is -$0.44 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.44 | – |
| FY2024 | Dec 31, 2024 | -$0.75 | – |
| FY2023 | Dec 31, 2023 | -$1.13 | – |
| FY2022 | Dec 31, 2022 | -$1.79 | – |
| FY2021 | Dec 31, 2021 | -$1.71 | – |
| FY2020 | Dec 31, 2020 | -$1.50 | – |
| FY2019 | Dec 31, 2019 | -$1.55 | – |
| FY2018 | Dec 31, 2018 | -$2.20 | – |
| FY2017 | Dec 31, 2017 | -$6.65 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.09 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.10 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.04 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.11 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.14 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.15 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.11 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.16 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.22 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.27 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.27 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.25 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.30 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.32 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.32 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.41 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.54 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.52 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.43 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.48 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.42 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.37 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.28 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.33 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.44 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.47 | – |
| Q4 FY2019 | Dec 31, 2019 | -$0.36 | – |
| Q3 FY2019 | Sep 30, 2019 | -$0.46 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.35 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.38 | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.29 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.87 | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.17 | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.39 | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.64 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?